Literature DB >> 10719047

RGS domain in the amino-terminus of G protein-coupled receptor kinase 2 inhibits Gq-mediated signaling.

H Usui1, M Nishiyama, K Moroi, T Shibasaki, J Zhou, J Ishida, A Fukamizu, T Haga, S Sekiya, S Kimura.   

Abstract

We have previously shown that not only G protein-coupled receptor kinase (GRK) 2, but also a catalytically inactive Lys220Trp GRK2 decreases endothelin (ET)-1-induced inositol 1,4,5-trisphosphate (IP3) formation, and demonstrated the presence of phosphorylation-independent desensitization mechanism. To clarify the role of GRK2 other than that as a kinase, we characterized an RGS (regulator of G protein signaling)-like domain in the amino-terminus of GRK2. Both GRK2(1-181) and GRK2(54-174) suppressed Ca2+ responses induced by angiotensin II (Ang II) and ET-1, and bound directly with Galphaq but not Galphas nor Galphai3 in the presence of GDP and AlF4-. These results demonstrate that GRK2 regulates Gq-mediated signaling negatively by direct interaction between its RGS domain and the transitional state of Galphaq, as well as through phosphorylation of activated receptors by its kinase domain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10719047     DOI: 10.3892/ijmm.5.4.335

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  14 in total

1.  GRK2 is an endogenous protein inhibitor of the insulin signaling pathway for glucose transport stimulation.

Authors:  Isao Usui; Takeshi Imamura; Hiroaki Satoh; Jie Huang; Jennie L Babendure; Christopher J Hupfeld; Jerrold M Olefsky
Journal:  EMBO J       Date:  2004-07-08       Impact factor: 11.598

2.  Characterization of the GRK2 binding site of Galphaq.

Authors:  Peter W Day; John J G Tesmer; Rachel Sterne-Marr; Leslie C Freeman; Jeffrey L Benovic; Philip B Wedegaertner
Journal:  J Biol Chem       Date:  2004-10-07       Impact factor: 5.157

Review 3.  Once and future signaling: G protein-coupled receptor kinase control of neuronal sensitivity.

Authors:  Richard T Premont
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

Review 4.  Regulators of G-protein signaling and their Gα substrates: promises and challenges in their use as drug discovery targets.

Authors:  Adam J Kimple; Dustin E Bosch; Patrick M Giguère; David P Siderovski
Journal:  Pharmacol Rev       Date:  2011-07-07       Impact factor: 25.468

Review 5.  G protein-coupled receptor kinases: more than just kinases and not only for GPCRs.

Authors:  Eugenia V Gurevich; John J G Tesmer; Arcady Mushegian; Vsevolod V Gurevich
Journal:  Pharmacol Ther       Date:  2011-08-26       Impact factor: 12.310

6.  The GRK2 Overexpression Is a Primary Hallmark of Mitochondrial Lesions during Early Alzheimer Disease.

Authors:  Mark E Obrenovich; Hector H Palacios; Eldar Gasimov; Jerzy Leszek; Gjumrakch Aliev
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-03-03

7.  A new non-canonical pathway of Gα(q) protein regulating mitochondrial dynamics and bioenergetics.

Authors:  Cristiane Benincá; Jesús Planagumà; Adriana de Freitas Shuck; Rebeca Acín-Perez; Juan Pablo Muñoz; Marina Mateus de Almeida; Joan H Brown; Anne N Murphy; Antonio Zorzano; Jose Antonio Enríquez; Anna M Aragay
Journal:  Cell Signal       Date:  2014-01-18       Impact factor: 4.315

8.  Phosphorylation-independent desensitization of GABA(B) receptor by GRK4.

Authors:  Julie Perroy; Lynda Adam; Riad Qanbar; Sébastien Chénier; Michel Bouvier
Journal:  EMBO J       Date:  2003-08-01       Impact factor: 11.598

Review 9.  Noncanonical Roles of G Protein-coupled Receptor Kinases in Cardiovascular Signaling.

Authors:  Sarah M Schumacher; Walter J Koch
Journal:  J Cardiovasc Pharmacol       Date:  2017-09       Impact factor: 3.105

10.  A peptide of the RGS domain of GRK2 binds and inhibits Gα(q) to suppress pathological cardiac hypertrophy and dysfunction.

Authors:  Sarah M Schumacher; Erhe Gao; Maya Cohen; Melissa Lieu; J Kurt Chuprun; Walter J Koch
Journal:  Sci Signal       Date:  2016-03-22       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.